A view to a kill: Ligands for Bcl-2 family proteins

Current Opinion in Chemical Biology

Volumn 6, Issue 4, 2002, Pages 479-485

  Rutledge, Stacey E ^a   Chin, Jason W ^b   Schepartz, Alanna ^a  

^a YALE UNIVERSITY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCIN A1; LIGAND; PROTEIN BCL 2; TETROCARCIN; UNCLASSIFIED DRUG;

APOPTOSIS; GENE OVEREXPRESSION; HOMEOSTASIS; HUMAN; MOLECULAR EVOLUTION; NONHUMAN; PROTEIN DETERMINATION; REGULATORY MECHANISM; REVIEW;

EID: 0036679688     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(02)00352-6     Document Type: Review

References (49)

1. Programmed cell death: Alive and well in the new millennium
2. Apoptosis in the pathogenesis and treatment of disease
3. The hallmarks of cancer
4. A matter of life and death
5. Apoptosis and tumourigenesis
6. Apoptosis: A link between cancer genetics and chemotherapy
7. Signaling pathways in apoptosis as potential targets for cancer therapy
8. Apoptosis-regulating proteins as targets for drug discovery
9. From bench to clinic with apoptosis-based therapeutic agents
10. Synthetic peptides and non-peptidic molecules as probes of structure and function of bcl-2 family proteins and modulators of apoptosis
11. Life-or-death decisions by the bcl-2 protein family
12. The bcl-2 protein family
13. Biochemical pathways of caspase activation during apoptosis
14. Bax and other pro-apoptotic bcl-2 family 'killer-proteins' and their victim, the mitochondrion
15. BH3-only proteins - Essential initiators of apoptotic cell death
16. Bak BH3 peptides antagonize bcl-xl function and induce apoptosis through cytochrome c-independent activation of caspases
17. Regulation of apoptosis by BH3 domains in a cell-free system
18. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-b cells
19. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell-death
20. Identification of small-molecule inhibitors of interaction between the BH3 domain and bcl-x(l)
21. Novel anticancer drug discovery
22. Overexpression of bcl-x protein in primary breast cancer is associated with high tumor grade and nodal metastases
23. Expression of apoptosis-regulatory genes in lung tumour cell lines: Relationship to p53 expression and relevance to acquired drug resistance
24. Structure of bax: Coregulation of dimer formation and intracellular localization
25. Solution structure of bid, an intracellular amplifier of apoptotic signaling
26. Solution structure of the proapoptotic molecule bid: A structural basis for apoptotic agonists and antagonists
27. X-ray and NMR structure of human bcl-xl, an inhibitor of programmed cell death
28. Solution structure of the antiapoptotic protein bcl-2
29. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homolog
30. Solution structure of a bcl-2 homolog from kaposi sarcoma virus
31. Structure of bcl-x(l)-bak peptide complex: Recognition between regulators of apoptosis
32. Rationale for bcl-xl/bad peptide complex formation from structure, mutagenesis, and biophysical studies
33. Virgin HWt: Identification of the in vivo role of a viral bcl-2
34. Kaposi's sarcoma-associated herpesvirus: A new DNA tumor virus
35. Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6
36. The emerging power of chemical genetics
37. Interaction, assembly and processing - At the chemistry biology interface - Overview
38. Structure-based discovery of an organic compound that binds bcl-2 protein and induces apoptosis of tumor cells
39. Reactions of salicylaldehydes with alkyl cyanoacetates on the surface of solid catalysts: Syntheses of 4H-chromene derivatives
40. Discovery of small-molecule inhibitors of bcl-2 through structure-based computer screening
41. A novel approach for characterizing protein ligand complexes: Molecular basis for specificity of small-molecule bcl-2 inhibitors
42. Antimycin A mimics a cell-death-inducing bcl-2 homology domain 3
43. Biophysical characterization of recombinant human bcl-2 and its interactions with an inhibitory ligand, antimycin A
44. Tetrocardin a inhibits mitochondrial functions of bcl-2 and suppresses its anti-apoptotic activity
45. Synthesis of tetrocardin derivatives with specific inhibitory activity towards bcl-2 functions
46. The atomic structure of protein - Protein recognition sites
47. Principles of protein-protein interactions
48. Design and evolution of a miniature bcl-2 binding protein
49. Protein transduction technology